NIM811
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NIM811, covering 2020-12-19 to 2020-12-19. Get the full timeline:
Most recent: Clinical Trial Update: Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients [Phase 2]